Product approval information for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for short ragweed pollen approved for use in adults 18 through 65 years of age.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7fjUh3l
No comments:
Post a Comment